Sharepoint Solutions
PRODUCTS
-
![AKTA readyflux single-use tangential flow filtration systems]( "Automated, Single-Use Systems For TFF At Multiple Scales")
Platform of automated, single-use systems for tangential flow filtration at multiple scales.
-
![Equipment Manager 2]( "Minimize Risk With Interactive Logbooks")
Guide operators through dynamic workflows from equipment startup to maintenance.
-
![gentleMACS Dissociator]( "gentleMACS™ Dissociator")
The gentleMACS™ Dissociator is a benchtop instrument for the semi-automated dissociation of tissues into single-cell suspensions or thorough homogenates.
-
![TWIST Mini Extruder Kit (Bucket size)]( "All-Inclusive Modular Liposome Extrusion Systems")
The TWIST™ Mini Liposome Extruder System is an all-inclusive modular liposome extrusion system. The intuitive design allows novice and expert users the ability to create liposome particles ranging from 50 nm to 10 um in diameter. With the heat block and extruder base, users have extended liposome creation capabilities and an easy, ergonomic set up. The TWIST™ System is the perfect solution for small scale R&D and liposome exploration projects.
-
![GettyImages-1413607446-vial-syringe-liquid-scientist-glove]( "Reliable Filling Process. Easy, Ready-To-Use Products")
Our injectable plants offer pre-filled water for injection (WFI) syringes in different sizes and volumes, produced according to European Pharmacopoeia (Ph. Eur.) and the United States Pharmacopeia (USP) requirements.
WHITE PAPERS AND CASE STUDIES
-
![data technology in hands 450x300]( "Raise The Bar: Setting New Standards For The eCOA Industry")
Raise The Bar: Setting New Standards For The eCOA IndustryA paradigm shift may be necessary to increase the adoption of Electronic Clinical Outcome Assessments (eCOA) in clinical research. Explore six pivotal areas where eCOA standards can be improved.
-
![GettyImages-1039397968 trial timing]( "Partnering For Precision In An IPF Study: Securing Timely Deliverables And Key Endpoints")
Partnering For Precision In An IPF Study: Securing Timely Deliverables And Key EndpointsA pharmaceutical company enlisted Worldwide Clinical Trials to help achieve on-time results for their Phase IIa IPF clinical trial, enabling them to manage vendors and meet challenging deadlines.
-
![Outsourcing Business Human Resources--GettyImages-1305829382]( "Enabling CDMOs To Focus On Core Priorities")
Enabling CDMOs To Focus On Core PrioritiesExplore innovative solutions for CDMO's striving to remain competitive as the biopharmaceutical market grows and evolves.
-
![GettyImages-1197955157-finances-money-financial-valuation]( "Taking Research In-House With CRIO: SciTech's Multi-Center Phase 1 Study")
Taking Research In-House With CRIO: SciTech's Multi-Center Phase 1 StudyExplore the success story of an early-stage clinical pharmaceutical company that effectively navigated funding constraints when conducting its Phase 1 study without a third-party CRO.
-
![GettyImages-1266320932 syringe, filling, lab]( "Navigating The Complexities Of Pre-Filled Syringe Manufacturing")
Navigating The Complexities Of Pre-Filled Syringe ManufacturingDrawing on our extensive expertise in sterile injectables (SI), here, we highlight practical strategies and proven solutions designed to help navigate challenges and support the reliable, scalable production of high-quality PFS therapies for patients worldwide.
-
![Horizontal Optical Comparator]( "Inspecting On The Edge — Understanding Punch Tip Wear")
Inspecting On The Edge — Understanding Punch Tip WearWhy is a horizontal optical comparator highly recommended for tablet manufacturers as a measuring tool for punch tip inspection, and what strategies can be used to detect, reduce, and prevent tip wear?
-
![GettyImages-1180547354 clinical trial tablet research]( "BioIVT Collaborates With IDBS To Deploy IDBS E-WorkBook And Reduce Study Cycle Times")
BioIVT Collaborates With IDBS To Deploy IDBS E-WorkBook And Reduce Study Cycle TimesLearn about a collaboration that has enabled BioIVT to enhance efficiency and responsiveness to its biopharmaceutical clients.
-
![Risk Management-GettyImages-665231256]( "Flexible Integrations To Reduce Risks And Increase Efficiencies")
Flexible Integrations To Reduce Risks And Increase EfficienciesLearn how a trial team kept the blind of central lab samples and patient treatment across a Phase III and extension trial, whilst optimizing the supply chain.
-
![GettyImages-547131922 research, regulatory, lab]( "FDA's Regenerative Medicine Advanced Therapy (RMAT) Program")
FDA's Regenerative Medicine Advanced Therapy (RMAT) ProgramRMAT qualification requires preliminary clinical evidence demonstrating the potential to address an unmet medical need. This designation grants benefits like intensive guidance and faster FDA review.
-
![rules, policies, regulatory documents-GettyImages-1438925546]( "Annex 1: Sterile Fill/Finish For Early Phase Clinical Supplies")
Annex 1: Sterile Fill/Finish For Early Phase Clinical SuppliesMeeting stringent requirements for sterile fill/finish operations hinges on robust contamination control strategies, advanced isolator technology, and rigorous integrity testing to ensure patient safety.
-
![Business meeting-GettyImages-1317387050]( "How Syneos Health Tackles Protocol Complexities")
How Syneos Health Tackles Protocol ComplexitiesExplore solutions employed by Syneos Health, a global contract research organization, to optimize Phase IIV clinical trials, particularly under a complex adaptive trial protocol.
-
![GettyImages-172962854 screen]( "OEE And Product Inspection")
OEE And Product InspectionExplore the calculation of Overall Equipment Effectiveness (OEE) and the impact of product inspection equipment on OEE in the pharmaceutical industry.
NEWS
-
Diasorin Submits The LIAISON NES Point-Of-Care Molecular Diagnostics System And 4-Plex Respiratory Panel To The FDA For 510(k) Clearance And CLIA Waiver7/2/2025
Diasorin announces the submission of a 510(k) premarket notification and CLIA waiver application to the U.S. Food and Drug Administration (FDA) for its LIAISON NES, a next-generation molecular POC testing platform.
-
Higgins, Timmons Introduce Legislation To Repeal EPA Rule On Chemical Manufacturing3/11/2025
Congressman Clay Higgins (R-LA) and Congressman William Timmons (R-SC) introduced legislation to repeal the U.S. Environmental Protection Agency’s (EPA) final procedural rule for new chemical reviews under the Toxic Substances Control Act (TSCA).
-
EPA Announces $7 Billion In Newly Available WIFIA Funding And Five New WIFIA Loan Approvals11/20/2025
The U.S. Environmental Protection Agency (EPA) has announced $6.5 billion in Water Infrastructure Finance and Innovation Act (WIFIA) funding available for water systems, with an additional $550 million available to states. Interested entities can apply for this funding through a rolling application process.
-
Advancing Regional Polio Vaccine Production With Fixed-Bed Bioreactor Technology4/9/2025
Batavia Biosciences, a leading contract development and manufacturing organization (CDMO), has pioneered a novel upstream bioprocessing method to enhance regional polio vaccine production.
-
Interior Cuts Red Tape To Speed Water Infrastructure In The West11/25/2025
The Department of the Interior today announced Secretary's Order 3446, which streamlines federally funded construction projects at Bureau of Reclamation facilities across the 17 Western states.